DNA Elements Recognizing NF-Y and Sp1 Regulate the Human Multidrug-Resistance Gene Promoter

Abstract

Regulation of the human multidrug resistance gene (hMDR1) was studied by mapping DNA elements in the proximal promoter necessary for efficient transcription. Transient transfection analysis in tumor cell lines (HCT116, HepG2, and Saos2) of promoter deletions identified several regulatory domains. These cell lines expressed hMDR1 mRNA. Removal of an element between +25 and +158 reduced promoter activity by 2-3-fold, whereas deletion of sequences from approximately -5000 to -138 base pairs gave a approximately 2-fold increase. The activity of the hMDR1 promoter (-137 to +25) was comparable in activity to the SV40 early promoter and enhancer combination. Deletion of the hMDR1 promoter between -86 and -44 reduced activity by 5-10-fold, identifying an important regulatory region. This minimal region (-88 to -37) activated transcription when inserted upstream of a synthetic promoter, suggesting that it acts independently of other regulatory sequences. Two DNA elements within 85 base pairs of the transcriptional start site were required to confer efficient gene expression. A double-point mutation in the Y box (inverted CCAAT box) between -70 and -80 reduced activity of the promoter by 5-10-fold, and a single-point mutation at -52 within a GC-rich element reduced activity by 3-fold. Thus, both the Y-box and GC elements must each remain intact for optimal promoter activity. DNA-binding analyses suggest that the transcription factor NF-Y, but not YB-1 or c/EBP, is most likely responsible for controlling the activity of the Y-box element in these tumor cell lines. DNA-binding analyses also suggest that Sp1, alone or in combination with other nuclear factors, likely controls the activity of the GC element.

Action of Transcription Factors in the Control of Transferrin Receptor Expression in Human Brain Endothelium

“…24 For example, Sp1 binds to a GC element within the pgp-1 promoter and is required for its basal expression in a number of cell lines. 25,26 The complex formed between the 330bp segment and hCMEC/D3 nuclear extract indicated a large DNA-binding protein associated with the promotor. Thus it is possible that an Sp-family member is a component of this complex.…”

Targeting the Y/CCAAT box in cancer: YB-1 (YBX1) or NF-Y?

“…Indeed, several labs showed that NF-Y is the activator, both under basal and under multiple inducing conditions. [102][103][104][105][106][107][108] In EMSAs performed with the Y/ CCAAT box, these authors detected NF-Y as the only DNAbinding complex. Specifically, Scotto's lab showed that a NF-YA dominant-negative mutant affects MDR1 expression.…”

Induction of human MDR1 gene expression by 2-acetylaminofluorene is mediated by effectors of the phosphoinositide 3-kinase pathway that activate NF-κB signaling

“…Notably, the NF-Y binding site located at 782 to 773 mediates MDR1 activation by the histone deacetylase inhibitor trichostatin A and sodium butyrate (Jin and Scotto, 1998). This site, together with its adjacent Sp1 site (756 to 742), are important for the basal (Sundseth et al, 1997) and UV-induced up-regulation of MDR1 expression (Hu et al, 2000). A CAAT-like site (7120 to 7110) is involved in the upregulation of MDR1 in human drug-resistant HL60/ VCR line (Ogretmen and Safa, 2000).…”